The National Comprehensive Cancer Network’s newly updated non-small cell lung cancer guideline adds sevabertinib as a treatment option for some patients with advanced disease, makes datopotamab ...
Indeed, the American College of Surgeons Commission on Cancer (CoC) mandates three mediastinal lymph nodes (N2) plus one hilar lymph node (N1) assessment during lung resections, a rule commonly known ...
Hosted on MSN
Staging and Treatment of Early-Stage Lung Cancer
Early-stage lung cancer usually refers to stages 1, 2, and 3A non-small cell lung cancer (NSCLC) as well as limited-stage small cell lung cancer (SCLC). You may have no symptoms in these early stages ...
For years, the default definitive treatment for patients with early-stage I non–small cell lung cancer (NSCLC) has been surgical resection, typically minimally invasive lobectomy with systematic lymph ...
In this study, researchers evaluated patients who had incomplete cCRT or experienced progression during or within 42 days of receiving cCRT, with an aim of identifying risk factors for these outcomes.
In patients with locally advanced non–small cell lung cancer (NSCLC), combining PET with invasive staging methods led to “relevant changes” of target volumes in 10% of cases, researchers reported.
Circular tumor DNA (ctDNA) positivity is associated with poorer survival and higher recurrence rates among patients with non–small cell lung cancer (NSCLC), but early detection may allow for timely ...
Ask a clinical question and tap into Healio AI's knowledge base. Lung cancer in general, and non-small cell lung cancer (NSCLC) in particular, is often asymptomatic in the early stages of the disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results